Dundon, Jondrex G.

HRN: 25-13-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/26/2025
05/06/2025
IV
50 Mg
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action 
04/29/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/29/2025
05/06/2025
PO
4ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: